3084 Phase III trial of afatinib vs erlotinib in patients with squamous cell carcinoma (SCC) of the lung (LUX-Lung 8): EGFR molecular aberrations and survival outcomes

Saved in:

Bibliographic Details
Published in	European journal of cancer (1990) Vol. 51; p. S626
Main Authors	Goss, G.D, Felip, E, Cobo, M, Lu, S, Syrigos, K, Li, K.W, Zhou, C, Park, K, Solca, F, Krämer, N, Chand, V.K, Soria, J.C
Format	Journal Article
Language	English
Published	Elsevier Ltd 01.09.2015
Subjects	Hematology, Oncology and Palliative Medicine
Online Access	Get full text

Loading…

More Information
ISSN:	0959-8049 1879-0852
DOI:	10.1016/S0959-8049(16)31725-7